含左氧氟沙星方案治疗复治肺结核临床疗效的Meta分析

摘要/Abstract

摘要： 目的评价含左氧氟沙星方案治疗复治肺结核的临床疗效。方法计算机检索中国生物医学文献光盘数据库、中国期刊全文数据库、万方数字化期刊、维普中文科技期刊等数据库，检索年限：1994年—2008年。按纳入、排除标准纳入合格的随机对照研究并对其进行质量评价， Meta分析采用RevMan4.2.7软件进行。结果共纳入8篇研究，包括791例患者，但这些研究的质量普遍不高。Meta分析结果表明，一线抗结核药加左氧氟沙星在提高痰菌阴转率、促进病灶吸收方面，优于一线抗结核药治疗复治肺结核。其OR和95%CI分别为3.70［2.59，5.27］、3.10［2.25，4.28］。左氧氟沙星方案与单纯一线抗结核药治疗比较，可能促进空洞闭合，其OR和95%CI为2.41［1.50，3.89］，但RR随机（95%CI）为1.63［0.99，2.68］。不良反应方面无统计学差异，其OR和95%CI为0.94［0.58，1.53］。结论尽管有证据支持左氧氟沙星与一线抗结核药联用在提高痰菌阴转率、促进病灶吸收方面，优于一线抗结核药治疗复治肺结核。由于纳入研究的数量少、潜在的发表偏倚和质量不高，尚不能对其疗效得出肯定性的结论。因此，继续开展高质量、大样本的随机对照试验非常必要。

关键词: 结核, 肺/药物疗法, 氧氟沙星, Meta分析

Abstract: ObjectiveTo assess the clinical efficacy of combination regimens with Levofloxacin(LVFX) in retreatment of pulmonary tuberculosis. MethodsWe searched CBM, CNKI, Wan Fang Digitalization Periodical, and Wei Pu Chinese technology periodical from 1994 to 2006 for randomized controlled trials(RCTs), which were enrolled according to the criteria for inclusion and exclusion, the quality were evaluated and meta-analysis performed by RevMan4.2.7 software. ResultsWe found 8 trials including 791 patients with poor qualities. The meta-analysis showed that there were statistically significant differences on the rates of sputum negative and radiographic improvement between containing Levofloxacin group and control group (OR 3.70, 95% CI 2.59 to 5.27, and OR3.10, 95% CI 2.25 to 4.28). The rate of cavities closure in the study group maybe higher than that of the control(OR 2.41, 95% CI 1.50 to 3.89, RR 1.63, 95% CI 0.99 to 2.68) There was no difference on side effects(OR 0.94,95% CI 0.58 to 1.53). ConclusionsSo far, there are a few evidences to support the result, which the clinical efficacy on the rates of sputum negative and the radiographic improvement in the study group is better than that of the control.Due to few studies, potential publication bias, and low quality of trails, we could not draw reliable conclusions from the present data. High quality RCTs should be performed further.

Key words: Tuberculosis,pulmonary/drug therapy, Ofloxacin, Meta-analysis

杨立娟. 含左氧氟沙星方案治疗复治肺结核临床疗效的Meta分析[J]. 中国防痨杂志, 2009, 31(7): 415-419.

Yang Lijuan. Meta-analysis on clinical efficacy of combination regimens with levofloxacin in retreatment of pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2009, 31(7): 415-419.

[1]	南海, 张芸, 杨新婷, 段鸿飞. GeneXpert MTB/RIF对骨关节结核诊断价值的Meta分析[J]. 中国防痨杂志, 2020, 42(9): 973-980.
[2]	黄国军, 高源, 唐细良, 高晓, 白丽琼. 胸腺五肽辅助治疗复治菌阳肺结核疗效和安全性的Meta分析[J]. 中国防痨杂志, 2020, 42(6): 570-577.
[3]	马改霞,田黎明,王钰,邱磊,薛玲娜,鹿振辉,张惠勇,郭晓燕. 中西医结合治疗耐多药肺结核的系统评价/Meta分析的再评价[J]. 中国防痨杂志, 2020, 42(2): 95-100.
[4]	许金红,杨松,张立新,钟颖,邱倩. 中国耐多药结核病发病危险因素的Meta分析[J]. 中国防痨杂志, 2019, 41(12): 1301-1309.
[5]	姚利,盛健,王冰,戴希勇. 外周血结核感染T细胞斑点试验对脊柱结核诊断价值的Meta分析[J]. 中国防痨杂志, 2019, 41(10): 1084-1089.
[6]	李艳林,黎亮,唐秀芳,吴秀娟. 白细胞介素2基因-330T/G和白细胞介素6基因-174G/C多态性与结核病易感性的Meta分析[J]. 中国防痨杂志, 2018, 40(3): 263-268.
[7]	李艳林，黎亮，唐秀芳. 白细胞介素10基因-819C/T多态性与结核病易感性的Meta分析[J]. 中国防痨杂志, 2017, 39(7): 732-739.
[8]	郑文静么鸿雁孙谨芳亓晓王琦琦. Meta分析方法在结核病领域的应用及常见误区解析[J]. 中国防痨杂志, 2017, 39(6): 555-558.
[9]	吴芳妮黎友伦. GeneXpert MTB/RIF在HIV感染者中诊断结核感染效能的Meta分析[J]. 中国防痨杂志, 2017, 39(3): 269-276.
[10]	李继民，赵文博，李江红. 结核病防治服务新体系运行效果的Meta分析[J]. 中国防痨杂志, 2016, 38(11): 934-939.
[11]	张家泳丛守婧王涛汪保国. 中国肺结核患者家庭密切接触者活动性肺结核检出情况的Meta分析[J]. 中国防痨杂志, 2016, 38(10): 862-868.
[12]	王庆枫，王隽，王敬，段鸿飞，戈启萍，黄学锐，杜亚东，韩喜琴，初乃惠. 含不同剂量左氧氟沙星方案的抗耐多药结核病疗效研究[J]. 中国防痨杂志, 2015, 37(2): 161-166.
[13]	冉兵，蔡林. 基因芯片检测耐利福平结核分枝杆菌准确性的Meta分析[J]. 中国防痨杂志, 2015, 37(1): 56-65.
[14]	王前，宋媛媛，逄宇，王玉峰，欧阳琴，赵雁林. 耐氧氟沙星结核分枝杆菌对五种氟喹诺酮类药物交叉耐药的研究[J]. 中国防痨杂志, 2014, 36(6): 453-457.
[15]	李史来，陈伟生，黄钥藩，林少云，吴少仪，蔡清河. 含左氧氟沙星联合利福布丁方案治疗复治肺结核患者的疗效观察[J]. 中国防痨杂志, 2014, 36(5): 375-379.

含左氧氟沙星方案治疗复治肺结核临床疗效的Meta分析

Meta-analysis on clinical efficacy of combination regimens with levofloxacin in retreatment of pulmonary tuberculosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

友情链接